The real-world duration of the initial regimen of anti-retroviral therapy in HIV patients in Japan: an observational database analysis

The real-world duration of the initial regimen of anti-retroviral therapy in HIV patients in Japan: an observational database analysis - ART duration study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027282

Enrollment

1700

Registered

2017-05-31

Start date

2017-05-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a disease record of HIV (ICD-10 code: B20-B24) Patients with a prescription records of antiretroviral drugs during April 2008 and December 2016 Patients at age 18 years or older in the month of the begging of the initial ART

Exclusion criteria

Exclusion criteria: Patients with a disease record of HIV-2 infection (Japanese Disease Name Code: 8847288).

Design outcomes

Primary

Measure	Time frame
The duration of initial ART regimens by key drug class.	—

Countries

Japan

Contacts

Public ContactRyuta Sakuma

MSD K.K. Medical Affairs

ldgproject@merck.com03-6272-2043

Outcome results